LumiraDx Limited (LMDX) Fundamentals

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care.
SHARE INFORMATION
Market Cap$ 338,617,527
Shares Outstanding317,688,555
Float65,134,518
Percent Float25.78%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 421,428,000
Latest Fiscal EPS$ -0.20
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions47
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months779,047
Institutional Holdings Percent8.5%
Institutional Sold Previous 3 Months384,587
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 10.61
52 Week Low$ 0.77
52 Week High Change$ -85.91
21 Day Moving Average$ 1.2014
21 Day Extended Moving Average$ 1.2454
50 Day Moving Average$ 1.0764
50 Day Extended Moving Average$ 1.2331
200 Day Moving Average$ 3.1244
200 Day Extended Moving Average$ 3.0009
10 Day Average Volume641,774
20 Day Average Volume477,730
30 Day Average Volume358,845
50 Day Average Volume325,109
Alpha-0.098829
Beta0.8748
Standard Deviation0.204596
R20.076794
7 Day Price Change$ -0.15
7 Day Percent Change-10.07%
21 Day Price Change$ 0.27
21 Day Percent Change25.23%
30 Day Price Change$ 0.35
30 Day Percent Change35.35%
Month to Date Price Change$ -0.03
Month to Date Percent Change-2.19%
Quarter to Date Price Change$ 0.32
Quarter to Date Percent Change31.37%
180 Day Price Change$ -2.17
180 Day Percent Change-61.82%
200 Day Price Change$ -2.54
200 Day Percent Change-65.46%
Year to Date Price Change$ -7.57
Year to Date Percent Change-84.96%

LumiraDx Limited (LMDX) Key Ratios

PROFITABILITY
EBIT Margin-67.7%
EBITDA Margin-57.6%
Pre-Tax Profit Margin0.0%
Profit Margin Count-66.74%
Gross Margin35.6%
Profit Margin TOT-66.74%
INCOME STATEMENTS
Revenue$ 331,609,000
Revenue Per Share$ 2.0091
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book24.10
Total Debt To Equity21.30
Int Coverage-1.40
Current Ratio2.90
Leverage Ratio7.60
Quick Ratio1.60
Long Term Debt To Capital0.95
VALUATION MEASURES
PE Ratio-1.00
Enterprise Value$ 685,445,319
Price to Sales0.666967
Price to Free Cash-1.60
PE High Last 5 Years0.00
Price To Book24.10
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book24.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.30
Invoice Turnover1.30
Assets Turnover0.40
Return Assets-60.03
Return on Equity-378.69
Return on Capital-43.02

LumiraDx Limited (LMDX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEORon Zwanziger
Emplyoees1600
Last AuditUE
CIK0001685428
IndustryBiotechnology
SectorHealthcare
NAICSDiagnostic Imaging Centers(621512)
CONTACT INFO
AddressC/o Ocorian Trust (Cayman) Ltd
Windward 3, P.O. Box 1350
Grand Cayman, KY1-1108
Websitehttps://www.lumiradx.com
Facsimile-
Telephone+1 345 640-0540
Email-


Your Recent History
NASDAQ
LMDX
LumiraDx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.